Originally published November 13 2006
Is Clostridium difficile-associated disease linked to use of common stomach medication? (press release)
by NaturalNews
Clostridium difficile-associated disease (CDAD), often associated with antibiotic use, is recognized as a major avoidable cause of illness and death in hospital patients. CDAD also occurs in the community. Recently, controversy has surrounded a possible link of community-acquired CDAD to the use of proton pump inhibitors (PPIs), drugs commonly used to suppress acid production in the stomach.
Dial and colleagues, in a study using data from the United Kingdom's General Practice Research Database, identified patients in the community who were deemed to have CDAD because they had been prescribed the antibiotic vancomycin. (CDAD is the only indication for use of this antibiotic.) As in previous studies using other markers of CDAD, an increased risk of CDAD was associated with current use of PPIs. In a related commentary, Cunningham reviews the polarized debate around the pathogenesis of CDAD and notes that, although the findings of Dial and colleagues add weight to the evidence for an association between CDAD and PPI use, they do not settle the issue.
Contact: Dr. Sandra Dial
514-934-1934 x32336
Canadian Medical Association Journal
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml